BCM
Biomark Capital Management Portfolio holdings
AUM
$8.91M
This Quarter Return
-11.18%
1 Year Return
+97.06%
3 Year Return
+113.74%
5 Year Return
–
10 Year Return
–
AUM
$72.8M
AUM Growth
+$72.8M
(-11%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 16.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
| $61M | 83.87% |
1,602,562
| – | – |
|
2
ADMA Biologics
ADMA
$4.03B
| $11.6M | 15.93% |
1,433,304
| – | – |
|
|
MBVX
3
DELISTED
MABVAX THERAPEUTICS HLDGS INC
MBVX
| $142K | 0.2% |
197,641
| – | – |
|